Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Millipore
Manufacturing
MilliporeSigma opens $65M high-potency API facility
MilliporeSigma, Merck KGaA’s North American subsidiary, opened the doors to its $65 million high-potency API manufacturing facility.
Joseph Keenan
Jun 28, 2022 10:15am
For $780M, Exelead bolsters Merck KGaA's mRNA manufacturing
Feb 24, 2022 11:05am
Here comes the gene therapy wave. What now?
Oct 21, 2021 8:00am
Merck KGaA's new chief rejigs its U.S. management team
May 18, 2021 11:39am
MilliporeSigma is pumping $47M into two New England plants
Dec 8, 2020 1:12pm
Lonza plots 2 manufacturing suites for antibody-drug conjugates
Dec 2, 2020 11:30am
